OUE Healthcare Limited (5WA.SI)
- Previous Close
0.0230 - Open
0.0230 - Bid 0.0220 x --
- Ask 0.0230 x --
- Day's Range
0.0220 - 0.0230 - 52 Week Range
0.0180 - 0.0330 - Volume
31,000 - Avg. Volume
321,267 - Market Cap (intraday)
102.192M - Beta (5Y Monthly) 0.17
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date Aug 5, 2025 - Aug 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
OUE Healthcare Limited, an investment holding company, owns, operates, and invests in healthcare businesses in Singapore, China, Myanmar, Indonesia, and Japan. The company operates through Healthcare Operations, Healthcare Assets, Properties Under Development, and Investments. It is involved in the operation of hospitals, clinics and supply of medical equipment and pharmaceutical products; rental of investment properties and owned assets; development of medical facilities, healthcare-related assets, and integrated mixed-used projects; and investment real estate investment trust. OUE Healthcare Limited was formerly known as OUE Lippo Healthcare Limited and changed its name to OUE Healthcare Limited in April 2023. The company was incorporated in 2013 and is headquartered in Singapore. OUE Healthcare Limited is a subsidiary of OUE Limited.
www.ouehealthcare.com149
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 5WA.SI
View MorePerformance Overview: 5WA.SI
Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is STI Index (^STI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 5WA.SI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 5WA.SI
View MoreValuation Measures
Market Cap
102.19M
Enterprise Value
582.43M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.09
Price/Book (mrq)
0.36
Enterprise Value/Revenue
3.88
Enterprise Value/EBITDA
8.73
Financial Highlights
Profitability and Income Statement
Profit Margin
-3.99%
Return on Assets (ttm)
3.77%
Return on Equity (ttm)
3.44%
Revenue (ttm)
150.28M
Net Income Avi to Common (ttm)
-6M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
70.65M
Total Debt/Equity (mrq)
74.93%
Levered Free Cash Flow (ttm)
29.81M